Evidence mounts that depression can be treated with different medicines
by Kristen McCLure
The first double-blind, placebo-controlled study of minocycline for depression was recently done in Australia. This study added to the body of research that supports an inflammatory hypothesis of depression. This hypothesis deals with chronic inflammation in those who have depression and hypothesizes that reducing the inflammation treats the depression This is how this particular medicine acts to help. While the results were not statistically significant, long term results suggested that the quality of life of participants who received this treatment was dramatically improved as opposed to those that merely had the placebo. This is especially good news for people who have intractable resistant major depressive disorder as it may lend itself to the possibility of the use of a new drug class to help these people who are in pain.
Dean et al.,Australian & New Zealand Journal of Psychiatry
Vol 51, Issue 8, pp. 829 - 840 First published date: June-03-201710.1177/0004867417709357
Click here to post comments
Join in and write your own page! It's easy to do. How? Simply click here to return to Anxiety Disorder and Depression Commentary.